CVS - CVS Health Corp
This page shows which of the focused investors we track hold CVS and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2021 it was held by 12 managers with an aggregate reported value of $2.35B, which is 0.19% of the combined portfolio.
As of Q2 2021, 12 tracked institutional managers held CVS (CVS Health Corp) with an aggregate reported value of $2.35B — 0.19% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades CVS — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2021
- Ticker
- CVS
13F data is delayed and excludes shorts/non-13F assets.
Long holders
| 1 | Dodge & Cox - Dodge & Cox | 0.86% | Reduce -2.7% | 15,723,074 | $1.31B |
| 2 | Bill Nygren - Oakmark Funds | 1.14% | Reduce -0.0% | 8,550,865 | $713.48M |
| 3 | Richard Pzena - Pzena Investment Management | 0.40% | Add +0.0% | 1,235,580 | $103.1M |
| 4 | Christopher Davis - Davis Advisors | 0.27% | Reduce -0.1% | 780,426 | $65.12M |
| 5 | David Katz - Matrix Asset Advisors | 4.07% | Reduce -0.9% | 339,704 | $28.35M |
| 6 | Thomas Gayner - Markel Asset Management | 0.35% | - | 332,000 | $27.7M |
| 7 | Michael Burry - Scion Asset Management | 12.13% | Add +81.8% | 200,000 | $16.69M |
| 8 | Robert Olstein - Olstein Capital Management | 1.89% | - | 180,000 | $15.02M |
| 9 | Hillman Value Fund - Hillman Value Fund | 3.46% | Add +0.7% | 108,929 | $9.09M |
| 10 | Muhlenkamp - Muhlenkamp | 3.33% | Add +0.2% | 108,834 | $9.08M |
| 11 | Prem Watsa - Fairfax Financial Holdings | 0.07% | - | 26,500 | $2.21M |
Call holders — bullish via leverage
1 manager holds call options on CVS — a right to buy at strike. Notional value, not premium.
| 1 | Michael Burry - Scion Asset Management | Add +31.3% | 525,300 | $43.83M |
Loading holder history for CVS…